Incremental burden of cardiovascular comorbidity and psoriatic arthritis among adults with moderate‐to‐severe psoriasis in five European countries
Augustin, M., Vietri, J., Tian, H., Gilloteau, I.
Published in Journal of the European Academy of Dermatology and Venereology (01.08.2017)
Published in Journal of the European Academy of Dermatology and Venereology (01.08.2017)
Get full text
Journal Article
A multidimensional assessment of the burden of psoriasis: results from a multinational dermatologist and patient survey
Griffiths, C.E.M., Jo, S.‐J., Naldi, L., Romiti, R., Guevara‐Sangines, E., Howe, T., Pietri, G., Gilloteau, I., Richardson, C., Tian, H., Augustin, M.
Published in British journal of dermatology (1951) (01.07.2018)
Published in British journal of dermatology (1951) (01.07.2018)
Get full text
Journal Article
Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study
Long, G.V., Atkinson, V., Ascierto, P.A., Robert, C., Hassel, J.C., Rutkowski, P., Savage, K.J., Taylor, F., Coon, C., Gilloteau, I., Dastani, H.B., Waxman, I.M., Abernethy, A.P.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Secukinumab sustains good efficacy and favourable safety in moderate‐to‐severe psoriasis after up to 3 years of treatment: results from a double‐blind extension study
Bissonnette, R., Luger, T., Thaçi, D., Toth, D., Messina, I., You, R., Guana, A., Fox, T., Papavassilis, C., Gilloteau, I., Mrowietz, U.
Published in British journal of dermatology (1951) (01.10.2017)
Published in British journal of dermatology (1951) (01.10.2017)
Get full text
Journal Article
Cost‐effectiveness of secukinumab as first biologic treatment, compared with other biologics, for moderate to severe psoriasis in Germany
Augustin, M., McBride, D., Gilloteau, I., O'Neill, C., Neidhardt, K., Graham, C. N.
Published in Journal of the European Academy of Dermatology and Venereology (01.12.2018)
Published in Journal of the European Academy of Dermatology and Venereology (01.12.2018)
Get full text
Journal Article
Patient–dermatologist agreement in psoriasis severity, symptoms and satisfaction: results from a real‐world multinational survey
Griffiths, C.E.M., Augustin, M., Naldi, L., Romiti, R., Guevara‐Sangines, E., Howe, T., Pietri, G., Gilloteau, I., Richardson, C., Tian, H., Jo, S.J.
Published in Journal of the European Academy of Dermatology and Venereology (01.09.2018)
Published in Journal of the European Academy of Dermatology and Venereology (01.09.2018)
Get full text
Journal Article
Secukinumab significantly reduces psoriasis‐related work impairment and indirect costs compared with ustekinumab and etanercept in the United Kingdom
Warren, R.B., Halliday, A., Graham, C.N., Gilloteau, I., Miles, L., McBride, D.
Published in Journal of the European Academy of Dermatology and Venereology (01.12.2018)
Published in Journal of the European Academy of Dermatology and Venereology (01.12.2018)
Get full text
Journal Article
Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis
Stull, D.E., Griffiths, C.E.M., Gilloteau, I., Zhao, Y., Guana, A., Finlay, A.Y., Sherif, B., Houghton, K., Puig, L.
Published in British journal of dermatology (1951) (01.06.2018)
Published in British journal of dermatology (1951) (01.06.2018)
Get full text
Journal Article
Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from the CLEAR study
Blauvelt, A., Reich, K., Mehlis, S., Vanaclocha, F., Sofen, H., Abramovits, W., Zhao, Y., Gilloteau, I., Davenport, E., Williams, N., Guana, A., Tyring, S.
Published in Journal of the European Academy of Dermatology and Venereology (01.10.2017)
Published in Journal of the European Academy of Dermatology and Venereology (01.10.2017)
Get full text
Journal Article
3331 Quality of survival (QoS) concept framework to assess the quality of prolonged life in advanced melanoma (MEL): Principles and application related to treatment with nivolumab (NIVO)
Fallowfield, L, Nadler, E, Abernethy, A.P, Gilloteau, I, Greaney, M, Gater, A, Orsini, L, Subar, M, Dastani, H.B, Lyman, G.H
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
1222 Long-term clinical experiences of patients (pts) with non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC) or metastatic melanoma (MEL): A SEER-Medicare analysis
Nadler, E, Ashaye, A, Stokes, M, Yang, S, Xu, Y, Berger, A, Shaw, J.W, Gilloteau, I, Abernethy, A.P
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
AB1359 Systematic literature review of publications on indirect comparisons for biologic agents in RA
Schiff, M., Stam, W., Gilloteau, I., Poncet, C., Hochberg, M.
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article
PCN63 The Relative Value of Dasatinib Versus Imatinib as First-Line Treatment for Chronic Myeloid Leukemia
Betegon, L, Gilloteau, I, Martin, P, Woolmore, A, Oyagüez, I
Published in Value in health (01.11.2012)
Published in Value in health (01.11.2012)
Get full text
Journal Article
Psoriasis: clinical and epidemiological features and therapy issues
Bakulev, A. L., Fitileva, T. V., Novodezerkina, E. А., Gilloteau, I., Tian, Н., Howe, T., Pietri, G.
Published in Vestnik dermatologij i venerologij (01.08.2018)
Published in Vestnik dermatologij i venerologij (01.08.2018)
Get full text
Journal Article
PSY38 A UK Based Cost-Effectiveness Analysis of Dasatinib (Sprycel) 100mg Daily Compared to Imatinib (Glivec) 400mg Daily in Newly Diagnosed Patients With Chronic Myeloid Leukemia (CML)
Mealing, S, Taylor, M, Scott, D, Clark, J, Mckenna, M, Lebmeier, M, Gilloteau, I, Davis, C
Published in Value in health (01.06.2012)
Published in Value in health (01.06.2012)
Get full text
Journal Article
PMS29 Abatacept or Infliximab for Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate: A Trial-Based and Real-Life Cost-Consequence Analysis
Benucci, M, Stam, W, Gilloteau, I, Crocchiolo, D, Sennfält, K, Leclerc, A, Bengtsson, N, Maetzel, A, Lucioni, C
Published in Value in health (2011)
Published in Value in health (2011)
Get full text
Journal Article